---
$id: https://graph.org.ai/products/commodity/51342305
$type: Product
source: UNSPSC
code: "51342305"
title: "Ganciclovir"
class: "51342300"
classTitle: "Antiviral guanines"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ganciclovir

**UNSPSC Code**: 51342305
**Class**: [Antiviral guanines](Antiviral guanines.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a purine antagonist and antiviral agent with the molecular formula C9H13N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P9G3CKZ4P5, chemically known as 9-(1,3-dihydroxy-propoxymethane)guanine but generally known as ganciclovir, which bears US NIH Compound Identifier 3454. European Medicines Agency schedules Ganciclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07881MIG. The term GANCICLOVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules ganciclovir in its Anatomical Therapeutic Chemical (ATC) Classification. GANCICLOVIR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ganciclovir under HS 29335995 and SITC 51576. As of Q4 2014, GANCICLOVIR remains the US FDA Preferred Term for this commodity. Ganciclovir bears US NLM identifiers UMLS ID C0017066 and NCI Concept Code C517. SMILES: O(C(CO)CO)CN1C2[NH]C(NC(=O)C2NC1)N.

